{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:37Z","timestamp":1789799977177,"version":"4.0.1"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2705","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T23:35:51Z","timestamp":1417390551000},"page":"2663-2670","source":"Crossref","is-referenced-by-count":35,"title":["Differences and Interactions between Risk Factors for Coronary Spasm and Atherosclerosis -Smoking, Aging, Inflammation, and Blood Pressure-"],"prefix":"10.2169","volume":"53","author":[{"given":"Sumio","family":"Morita","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Japan"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Harada","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Morikawa","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Katoh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yasue","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 51: 2-17, 2008.","DOI":"10.1016\/j.jjcc.2008.01.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. Circ J 73: 394-403, 2009.","DOI":"10.1253\/circj.CJ-09-0033"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J 74: 1745-1762, 2010.","DOI":"10.1253\/circj.CJ-10-74-0802"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94: 266-271, 1996.","DOI":"10.1161\/01.CIR.94.3.266"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32: 2045-2051, 2012.","DOI":"10.1161\/ATVBAHA.108.179705"},{"key":"6","unstructured":"6. Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J 124: 32-38, 1992."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 87: 76-79, 1993.","DOI":"10.1161\/01.CIR.87.1.76"},{"key":"8","unstructured":"8. Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 72: 121-126, 2000."},{"key":"9","unstructured":"9. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92-105, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest 123: 958-965, 2013.","DOI":"10.1172\/JCI64096"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 75: 685-705, 2013.","DOI":"10.1146\/annurev-physiol-030212-183653"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sabatine MS, Morrow DA, Jablonski KA, et al. Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115: 1528-1536, 2007.","DOI":"10.1161\/CIRCULATIONAHA.106.649939"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yasue H, Matsuyama K, Matsuyama K, et al. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81: 482-490, 1990.","DOI":"10.1161\/01.CIR.81.2.482"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491-497, 1990.","DOI":"10.1161\/01.CIR.81.2.491"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. McWhorter VC, Ford LC, Butch AW. Analytical performance of the Synchron LX20 Pro, BN trade mark II and IMMAGE high sensitivity C-reactive protein assays and concordance in cardiovascular risk stratification. Clin Chim Acta 347: 71-79, 2004.","DOI":"10.1016\/j.cccn.2004.03.034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shibutani S, Osanai T, Ashitate T, et al. Coronary vasospasm induced in transgenic mouse with increased phospholipase C-&delta;1 activity. Circulation 125: 1027-1036, 2012.","DOI":"10.1161\/CIRCULATIONAHA.111.064303"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kugiyama K, Ota Y, Kawano H, et al. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina. Cardiovasc Res 47: 159-165, 2000.","DOI":"10.1016\/S0008-6363(00)00060-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Itoh T, Mizuno Y, Harada E, et al. Coronary spasm is associated with chronic low-grade inflammation. Circ J 71: 1074-1078, 2007.","DOI":"10.1253\/circj.71.1074"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yasue H, Hirai N, Mizuno Y, et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 70: 8-13, 2006.","DOI":"10.1253\/circj.70.8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lavi S, Prasad A, Yang EH, et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 115: 2621-2627, 2007.","DOI":"10.1161\/CIRCULATIONAHA.106.641654"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. Atherosclerosis 131: 195-202, 1997.","DOI":"10.1016\/S0021-9150(97)06106-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Noma K, Goto C, Nishioka K, et al. Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 25: 2630-2635, 2005.","DOI":"10.1161\/01.ATV.0000189304.32725.bd"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Xu CB, Lei Y, Chen Q, Pehrson C, Larsson L, Edvinsson L. Cigarette smoke extracts promote vascular smooth muscle cell proliferation and enhances contractile responses in the vasculature and airway. Basic Clin Pharmacol Toxicol 107: 940-948, 2010.","DOI":"10.1111\/j.1742-7843.2010.00610.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105: 1545-1547, 2002.","DOI":"10.1161\/hc1002.105938"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Alex MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 74: 13-40, 2012.","DOI":"10.1146\/annurev-physiol-012110-142315"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation 112: 862-869, 2005.","DOI":"10.1161\/CIRCULATIONAHA.104.520650"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17: 1192-1200, 2004.","DOI":"10.1016\/j.amjhyper.2004.05.023"},{"key":"28","unstructured":"28. Okumura K, Yasue H, Matsuyama K, et al. A study on coronary hemodynamics during acetylcholine-induced coronary spasm in patients with variant angina: endothelium-dependent dilation in the resistance vessels. J Am Coll Cardiol 19: 1426-1434, 1992."},{"key":"29","unstructured":"29. Sueda S, Kohno H, Fukuda H, Uraoka T. Coronary flow reserve in patients with vasospastic angina: correlation between coronary flow reserve and age or duration of angina. Coron Artery Dis 14: 423-429, 2003."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Muller JM, Davis MJ, Chilian WM. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res 32: 668-678, 1996.","DOI":"10.1016\/0008-6363(96)00111-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Laughlin MH, Turk JR, Schrage WG, Woodman CR, Price EM. Influence of coronary artery diameter on eNOS protein content. Am J Physiol Heart Circ Physiol 284: H1307-H1312, 2003.","DOI":"10.1152\/ajpheart.00792.2002"},{"key":"32","unstructured":"32. Nakagawa H, Morikawa Y, Mizuno Y, et al. Coronary spasm preferentially occurs at branch points: an angiographic comparison with atherosclerotic plaque. Circ Cardiovasc Interv 2: 97-104, 2009."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 98: 1154-1162, 2005.","DOI":"10.1152\/japplphysiol.00164.2004"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Morikawa Y, Mizuno Y, Harada E, et al. Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation. Coron Artery Dis 24: 177-182, 2013.","DOI":"10.1097\/MCA.0b013e32835cbef5"},{"key":"35","unstructured":"35. Glynn RJ, MacFadyen JG, Ridker PM. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem 55: 305-312, 2009."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yasue H, Mizuno Y, Harada E, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51: 1742-1748, 2008.","DOI":"10.1016\/j.jacc.2007.12.049"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 101: 1102-1108, 2000.","DOI":"10.1161\/01.CIR.101.10.1102"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 59: 655-662, 2012.","DOI":"10.1016\/j.jacc.2011.11.015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nakayama M, Yasue H, Yoshimura M, et al. T<sup>-786<\/sup>&rarr;C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99: 2864-2870, 1999.","DOI":"10.1161\/01.CIR.99.22.2864"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ito T, Yasue H, Yoshimura M, et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110: 89-94, 2002.","DOI":"10.1007\/s00439-001-0654-6"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation 105: 2024-2029, 2002.","DOI":"10.1161\/01.CIR.0000014613.36469.3F"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.2705\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:52:41Z","timestamp":1621446761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.2705\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":41,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2705","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}